You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
步長製藥(603858.SH):酒石酸美託洛爾片擬中標第五批全國藥品集採
格隆匯 06-24 16:41

格隆匯6月24日丨步長製藥(603858.SH)公佈,2021年6月23日,公司全資子公司陝西步長高新制藥有限公司(“步長高新”)參加了國家組織藥品集中採購和使用聯合採購辦公室組織的第五批全國藥品集中採購的投標工作。步長高新藥品酒石酸美託洛爾片擬中標本次集中採購。

擬中標價格:1.96元。規格:25mg*20片/板/盒。擬供應省(區):河北省、陝西省、甘肅省、青海省。

適應症:酒石酸美託洛爾片用於治療高血壓、心絞痛、心肌梗死、肥厚型心肌病、主動脈夾層、心律失常、甲狀腺功能亢進、心臟神經官能症等。近年來尚用於心力衰竭的治療,此時應在有經驗的醫師指導下使用。

經米內網查詢,2020年中國(城市公立,城市社區,縣級公立,鄉鎮衞生)年度銷售趨勢顯示,酒石酸美託洛爾片銷售額為7.9998億元。若步長高新後續簽訂採購合同並實施後,將有利於公司進一步擴大相關產品的銷售,提高市場佔有率,提升公司品牌影響力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account